Deutsche Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.17M Sell
465,831
-30,211
-6% -$271K ﹤0.01% 1313
2025
Q1
$3.72M Sell
496,042
-23,175
-4% -$174K ﹤0.01% 1379
2024
Q4
$3.9M Buy
519,217
+58,687
+13% +$441K ﹤0.01% 1442
2024
Q3
$3.5M Buy
460,530
+28,536
+7% +$217K ﹤0.01% 1419
2024
Q2
$2.67M Sell
431,994
-316,800
-42% -$1.96M ﹤0.01% 1486
2024
Q1
$3.8M Sell
748,794
-277,248
-27% -$1.41M ﹤0.01% 1358
2023
Q4
$6.15M Buy
1,026,042
+926,331
+929% +$5.55M ﹤0.01% 1162
2023
Q3
$706K Buy
99,711
+10,499
+12% +$74.3K ﹤0.01% 1918
2023
Q2
$628K Sell
89,212
-51,744
-37% -$364K ﹤0.01% 2231
2023
Q1
$1.18M Buy
140,956
+31,936
+29% +$266K ﹤0.01% 1994
2022
Q4
$1.25M Buy
109,020
+22,785
+26% +$262K ﹤0.01% 1906
2022
Q3
$1.09M Sell
86,235
-16,963
-16% -$214K ﹤0.01% 1909
2022
Q2
$1.09M Sell
103,198
-8,089
-7% -$85.5K ﹤0.01% 2115
2022
Q1
$1.81M Sell
111,287
-10,328
-8% -$168K ﹤0.01% 1957
2021
Q4
$1.69M Sell
121,615
-90,584
-43% -$1.26M ﹤0.01% 2089
2021
Q3
$3.05M Buy
212,199
+70,306
+50% +$1.01M ﹤0.01% 1790
2021
Q2
$2.24M Buy
141,893
+12,572
+10% +$199K ﹤0.01% 2110
2021
Q1
$1.32M Sell
129,321
-13,757
-10% -$140K ﹤0.01% 2482
2020
Q4
$1.07M Buy
143,078
+32,583
+29% +$243K ﹤0.01% 2389
2020
Q3
$380K Buy
110,495
+1,608
+1% +$5.53K ﹤0.01% 2788
2020
Q2
$518K Sell
108,887
-2,211,572
-95% -$10.5M ﹤0.01% 2600
2020
Q1
$4.64M Sell
2,320,459
-1,482,795
-39% -$2.97M ﹤0.01% 1289
2019
Q4
$13.1M Buy
3,803,254
+3,432,643
+926% +$11.8M 0.01% 960
2019
Q3
$1.06M Buy
370,611
+133,522
+56% +$382K ﹤0.01% 2263
2019
Q2
$896K Sell
237,089
-13,093
-5% -$49.5K ﹤0.01% 2880
2019
Q1
$2.03M Buy
250,182
+148,972
+147% +$1.21M ﹤0.01% 2487
2018
Q4
$816K Sell
101,210
-471,253
-82% -$3.8M ﹤0.01% 3000
2018
Q3
$4.37M Sell
572,463
-43,103
-7% -$329K ﹤0.01% 2287
2018
Q2
$3.53M Sell
615,566
-305,168
-33% -$1.75M ﹤0.01% 2551
2018
Q1
$4.39M Buy
920,734
+396,068
+75% +$1.89M ﹤0.01% 2318
2017
Q4
$2.57M Buy
524,666
+270,147
+106% +$1.32M ﹤0.01% 2532
2017
Q3
$1.33M Sell
254,519
-264,785
-51% -$1.39M ﹤0.01% 2772
2017
Q2
$2.89M Buy
519,304
+295,626
+132% +$1.64M ﹤0.01% 2293
2017
Q1
$1.88M Sell
223,678
-293,851
-57% -$2.47M ﹤0.01% 2267
2016
Q4
$3.27M Sell
517,529
-68
-0% -$430 ﹤0.01% 1928
2016
Q3
$2.28M Buy
517,597
+267,872
+107% +$1.18M ﹤0.01% 2242
2016
Q2
$705K Sell
249,725
-40,132
-14% -$113K ﹤0.01% 3044
2016
Q1
$817K Buy
289,857
+189,292
+188% +$534K ﹤0.01% 2898
2015
Q4
$1.04M Sell
100,565
-34,789
-26% -$358K ﹤0.01% 2801
2015
Q3
$1.54M Buy
135,354
+44,993
+50% +$512K ﹤0.01% 2624
2015
Q2
$1.35M Buy
90,361
+52,486
+139% +$782K ﹤0.01% 2733
2015
Q1
$340K Buy
37,875
+27,075
+251% +$243K ﹤0.01% 3398
2014
Q4
$130K Sell
10,800
-30,350
-74% -$365K ﹤0.01% 4278
2014
Q3
$400K Buy
41,150
+21,834
+113% +$212K ﹤0.01% 3526
2014
Q2
$244K Sell
19,316
-73,905
-79% -$934K ﹤0.01% 3851
2014
Q1
$985K Buy
93,221
+72,448
+349% +$766K ﹤0.01% 2868
2013
Q4
$157K Buy
20,773
+20,073
+2,868% +$152K ﹤0.01% 3800
2013
Q3
$5K Sell
700
-180,687
-100% -$1.29M ﹤0.01% 4926
2013
Q2
$280K Buy
+181,387
New +$280K ﹤0.01% 3581